DL
WX

Delta Lloyd’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Delta Lloyd’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-190,900
Closed -$5.23M – 634
2013
Q3 		$5.23M Sell
190,900
-160,800
-46% -$3.81M 0.2% 108
2013
Q2 		$7.39M Buy
+351,700
New +$6.87M 0.28% 77

Other funds holding WX

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Delta Lloyd's WX Position: Q4 2013 in Review

Delta Lloyd sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2013, closing a stake of 190,900 shares — an estimated $5.23M sold.

Delta Lloyd first reported a position in WX in Q2 2013 and held it in 2 quarters. The position peaked at $7.39M in Q2 2013. 164 funds tracked by Wall St. Rank hold WX as of Q4 2013.

  • Delta Lloyd reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2013 after selling out during the quarter.
  • Delta Lloyd sold 190,900 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2013, an estimated $5.23M.
  • Delta Lloyd first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 2 quarters.
  • Delta Lloyd's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.39M in Q2 2013.
  • 164 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2013.

Based on Delta Lloyd's 13F filing for Q4 2013, filed 12 Feb 2014.